By Michael Rule
Last January, NCPA urged Congress to investigate soaring generic drug prices after a member survey found that acquisition costs for some drugs had increased by more than 1,000%, but that reimbursement to pharmacies did not keep up. This call was recently answered by Sen. Bernie Sanders (I-Vt.) and Rep. Elijah E. Cummings (D-Md.) who launched an inquiry.
Continue reading ‘Members of Congress Scrutinize Sky-rocketing Costs of Generic Drugs’
By Michael Rule
For years, NCPA has been at the forefront in calling for greater transparency in the operations of pharmacy benefit managers (PBMs), from highlighting difficulties plan sponsors often have in auditing their PBM to noting PBM practices that may increase costs to plans while increasing profits for the PBMs. While the PBMs claim there is already adequate transparency, their policies are drawing increased scrutiny.
Continue reading ‘Payers Call for Greater PBM Transparency’
Published October 30, 2014
Medicaid , Medicare , MTM , pharmacist , pharmacy benefit managers
Tags: Medicaid, Medicare, medication therapy management, NCPA Convention, pharmacist, pharmacy benefit managers
By Kurt A. Proctor, Ph.D., RPh, NCPA Senior Vice President, Strategic Initiatives
After a great NCPA Annual Meeting in Austin, we weren’t done. On Wednesday, October 22nd we kept the momentum going with a day-long “Networking for High Performance Pharmacies” program for a standing room only crowd of 140 industry leaders. This provocative program afforded like-minded pharmacists not only the opportunity to get to know each other but to engage with public and private payers to hear about their plans for pay-for-performance and quality related network inclusion criteria.
Continue reading ‘The Morning After’
By Kevin Schweers
Claims by pharmacy benefit managers (PBMs) that a massive cost increase would result from legislation giving Medicare seniors in medically underserved areas more convenient access to discounted or “preferred” copays are “theoretically baseless,” a noted health care economist and antitrust expert argues in a new analysis.
Continue reading ‘Health Economist Shreds PBMs’ Claim of Large Cost Increase from “Any Willing Pharmacy” Medicare Proposal’
By Michael Rule, Associate Director of Grassroots and Public Affairs
From a grassroots perspective, 2013 should be a year that is long remembered by pharmacists. Due to pharmacist engagement, independent community pharmacists achieved pro-patient, pro-pharmacist successes at both the state and federal level and continued to build relationships with legislators through hosting pharmacy visits. Continue reading ‘Grassroots Efforts Yield Successes in 2013: Keep it up in 2014′
NCPA ran a public service announcement (PSA) at NASCAR’s Homestead Miami Speedway during the weekend of Nov. 15-17, and we’ve posted here and on You Tube a short video summary from the event.
Continue reading ‘NASCAR Fans Hear About PBM Abuses’
By Michael Rule, Associate Director of Public Affairs and Grassroots Advocacy
Congress recently adjourned for its annual August recess. During this five week period, Senators and Representatives will be spending much time at home, touring the state or district and listening to constituents. For independent community pharmacists, this presents a tremendous opportunity to educate members of Congress on the role you play in the healthcare system and in your communities, and on the patient services you provide. This is also an opportunity to advocate for common sense reforms regarding abusive audits by pharmacy benefits managers (PBMs) and to seek reversal of a CMS rule regarding home delivery diabetes test supplies (DTS). You also can educate elected officials on the unintended consequences of some legislative efforts regarding pharmacy compounding.
Continue reading ‘Congress’ August Recess Provides Opportunities to Promote Common Sense Policy’